Search

Search Constraints

You searched for: Author/Creator Assmann, Susan F.

Search Results

1. Baseline Distribution of Participants With Depression and Impaired Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial. (March 2015)

2. Baseline Distribution of Participants With Depression and Impaired Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial. (March 2015)

3. Clinical outcomes in a cohort of patients with heparin‐induced thrombocytopenia. Issue 8 (26th April 2017)

4. Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT. (21st November 2016)

5. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) Trial. Issue 7 (8th July 2016)

6. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) Trial. Issue 7 (July 2016)

7. Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery. Issue 4 (5th March 2019)

8. Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial. (March 2016)

10. Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial. Issue 1 (6th January 2015)